Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

about

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

Item

http://www.wikidata.org/entity/Q55109090

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@en

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@nl

type

Item

label

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@en

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@nl

prefLabel

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@en

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@nl

P1476

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

@en

P2093

Binyam Bezabeh

http://www.w3.org/2001/XMLSchema#string

Cui Chen

http://www.w3.org/2001/XMLSchema#string

Darrin Sabol

http://www.w3.org/2001/XMLSchema#string

David A Tice

http://www.w3.org/2001/XMLSchema#string

Emily E Bosco

http://www.w3.org/2001/XMLSchema#string

Haihong Zhong

http://www.w3.org/2001/XMLSchema#string

Jiping Zha

http://www.w3.org/2001/XMLSchema#string

Joanne Ayriss

http://www.w3.org/2001/XMLSchema#string

John Meekin

http://www.w3.org/2001/XMLSchema#string

Karma DaCosta

http://www.w3.org/2001/XMLSchema#string

P2860

The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136

RET recognition of GDNF-GFRα1 ligand by a composite binding site promotes membrane-proximal self-association

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Distinct roles for GFRalpha1 and GFRalpha2 signalling in different cranial parasympathetic ganglia in vivo

Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts.

A syngeneic variance library for functional annotation of human variation: application to BRCA2

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.

Characterization of a multicomponent receptor for GDNF.

Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma.

P304

22960-22975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25160

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29796165

http://www.w3.org/2001/XMLSchema#string

P932

5955426

http://www.w3.org/2001/XMLSchema#string